News

The BMJ5d

New cystic fibrosis drug fast tracked to UK patients

A new once daily triple drug treatment for cystic fibrosis is set to be “immediately funded” by NHS England following recommendation from the National Institute for Health and Care Excellence (NICE).1 ...
Nursing Times6d

NICE fast-tracking of new cystic fibrosis drug marks ‘positive step’

NHS patients in England with cystic fibrosis will be among the first in Europe to access a new treatment for their condition, ...

Prime Medicine Announces Additional Funding Of Up To $24 Million From The Cystic Fibrosis Foundation To Advance Prime Editing Treatments For Cystic Fibrosis

Expanded funding builds on the initial agreement to accelerate development of Prime Editors for Cystic Fibrosis (CF) -- -- Prime Medicin ...

Vertex Announces Marketing Authorization in Canada for ALYFTREK, a Once-Daily Next-Generation CFTR Modulator for the Treatment of Cystic Fibrosis

Vertex Pharmaceuticals today announced that Health Canada has granted Marketing Authorization for PrALYFTREKTM (vanzacaftor/tezacaftor/deutivacaftor), a new triple combination therapy for patients ...